As tumor size concerns, pT1a, b, c were 7.6%, 37.7 %, 54.8 %, respectively; ER and/or PgR were positive in 83.7 % of the tumors; Her-2 was positive in 10.8 % (70 % also ER+) of the tumors; Ki-67 was >15 % in 28 % of the tumors; ductal, lobular, other histotypes were recorded in 87.4 %, 6.3 %, 6.3 % of the tumors. This evidence concerns the gene PGR and neoplasm.